Clinical trials
Prediabetic State trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cambridge University Hospitals NHS Foundation Trust | 2 |
| Imperial College London | 2 |
| Aberystwyth University | 1 |
| Alere San Diego | 1 |
| Gelesis, Inc. | 1 |
| India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals | 1 |
| Leeds Beckett University | 1 |
| Neurovalens Ltd. | 1 |
| Nottingham Trent University | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prediabetic State | 19 |
| Obesity | 5 |
| Overweight | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Glucose Intolerance | 3 |
| Insulin Resistance | 3 |
| Metabolic Syndrome | 2 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Cognitive Dysfunction | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.